Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Hypermutation In Pancreatic Cancer

    Access Status
    Fulltext not available
    Authors
    Humphris, J.
    Patch, A.
    Nones, K.
    Bailey, P.
    Johns, A.
    Mckay, S.
    Chang, D.
    Miller, D.
    Pajic, M.
    Kassahn, K.
    Quinn, M.
    Bruxner, T.
    Christ, A.
    Harliwong, I.
    Idrisoglu, S.
    Manning, S.
    Nourse, C.
    Nourbakhsh, E.
    Stone, A.
    Wilson, P.
    Anderson, M.
    Fink, J.
    Holmes, O.
    Kazakoff, S.
    Leonard, C.
    Newell, F.
    Waddell, N.
    Wood, S.
    Mead, R.
    Xu, Q.
    Wu, J.
    Pinese, M.
    Cowley, M.
    Jones, M.
    Nagrial, A.
    Chin, V.
    Chantrill, L.
    Mawson, A.
    Chou, A.
    Scarlett, C.
    Pinho, A.
    Rooman, I.
    Giry-Laterriere, M.
    Samra, J.
    Kench, J.
    Merrett, N.
    Toon, C.
    Epari, K.
    Nguyen, N.
    Barbour, A.
    Zeps, Nikolajs
    Jamieson, N.
    McKay, C.
    Carter, C.
    Dickson, E.
    Graham, J.
    Duthie, F.
    Oien, K.
    Hair, J.
    Morton, J.
    Sansom, O.
    Gruetzmann, R.
    Hruban, R.
    Maitra, A.
    Iacobuzio-Donahue, C.
    Schulick, R.
    Wolfgang, C.
    Morgan, R.
    Lawlor, R.
    Rusev, B.
    Corbo, V.
    Salvia, R.
    Cataldo, I.
    Tortora, G.
    Tempero, M.
    Hofmann, O.
    Eshleman, J.
    Pilarsky, C.
    Scarpa, A.
    Musgrove, E.
    Gill, A.
    Pearson, J.
    Grimmond, S.
    Waddell, N.
    Biankin, A.
    Date
    2017
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Humphris, J. and Patch, A. and Nones, K. and Bailey, P. and Johns, A. and Mckay, S. and Chang, D. et al. 2017. Hypermutation In Pancreatic Cancer. Gastroenterology. 152 (1): pp. 68-74.e2.
    Source Title
    Gastroenterology
    DOI
    10.1053/j.gastro.2016.09.060
    ISSN
    0016-5085
    URI
    http://hdl.handle.net/20.500.11937/70852
    Collection
    • Curtin Research Publications
    Abstract

    © 2017 AGA Institute Pancreatic cancer is molecularly diverse, with few effective therapies. Increased mutation burden and defective DNA repair are associated with response to immune checkpoint inhibitors in several other cancer types. We interrogated 385 pancreatic cancer genomes to define hypermutation and its causes. Mutational signatures inferring defects in DNA repair were enriched in those with the highest mutation burdens. Mismatch repair deficiency was identified in 1% of tumors harboring different mechanisms of somatic inactivation of MLH1 and MSH2. Defining mutation load in individual pancreatic cancers and the optimal assay for patient selection may inform clinical trial design for immunotherapy in pancreatic cancer.

    Related items

    Showing items related by title, author, creator and subject.

    • Emerging role of the KRAS-PDK1 axis in pancreatic cancer
      Ferro, R.; Falasca, Marco (2014)
      Pancreatic cancer is a highly aggressive tumour that is very resistant to treatments and it is rarely diagnosed early because of absence of specific symptoms. Therefore, the prognosis for this disease is very poor and it ...
    • Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals
      Abrams, S.; Lertpiriyapong, K.; Yang, L.; Martelli, A.; Cocco, L.; Ratti, S.; Falasca, Marco; Murata, R.; Rosalen, P.; Lombardi, P.; Libra, M.; Candido, S.; Montalto, G.; Cervello, M.; Steelman, L.; McCubrey, J. (2018)
      Pancreatic ductal adenocarcinoma (PDAC) is an aggressive, highly metastatic malignancy and accounts for 85% of pancreatic cancers. PDAC patients have poor prognosis with a five-year survival of only 5–10%. Mutations at ...
    • Key role of phosphoinositide 3-kinase class IB in pancreatic cancer
      Edling, C.; Selvaggi, F.; Buus, R.; Maffucci, T.; Di Sebastiano, P.; Friess, H.; Innocenti, P.; Kocher, H.; Falasca, Marco (2010)
      Purpose: Phosphoinositide 3-kinase (PI3K) signaling is well established as important in cancer. To date most studies have been focused on the PI3K/p110a isoform, which has been found to be mutated in several different ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.